Maven VCTs Face Last Call as Tax Relief Shrinks to 20% by April 6

The core transaction is now complete. Maven Income and Growth VCT 5 PLC has successfully raised its full fundraising limit of £12.5 million, including the full £5 million over-allotment facility. This is not an isolated event but the final piece of a larger, strategic capital allocation. It forms part of a combined £30 million offering across four Maven VCTs, a coordinated move by a manager with significant scale and a proven track record.

The strategic rationale here is clear. Maven Capital Partners is deploying fresh capital into a portfolio of regional unquoted businesses that has demonstrated consistent value creation. The manager's own performance is instructive: in the year ended November 2025, the trust completed two profitable private company exits and achieved a NAV total return of 152.82p per share. More broadly, the combined Maven VCTs have a history of profitable exits, generating £53.9 million in proceeds against a cost of £19.4 million over a recent 12-month period. This is the thesis of a quality manager making a conviction buy-deploying capital into a disciplined, high-conviction strategy with a demonstrable path to returns.

Yet the long-term impact of this capital deployment is now constrained by an imminent external factor. The entire VCT structure operates under a specific tax regime, and the timing of this raise places it squarely in the path of a policy shift. The capital is being raised for the 2025/2026 tax year, with final allotments scheduled for April 2. This suggests the market is pricing in a potential change to the VCT tax incentive that could take effect for the next tax year. For institutional investors, this creates a classic "buy now" dynamic: the strategic rationale for deploying capital into a quality manager's portfolio remains intact, but the window for doing so under the current favorable tax terms is closing.

The Structural Tailwind: A Temporary Tax Incentive

The immediate catalyst for this capital deployment is a structural policy shift. Starting April 6, 2026, the upfront income tax relief for VCT investors will fall from 30% to 20%. This is not a minor adjustment; it directly impacts the risk-adjusted return profile of the investment. For a taxpayer with sufficient liability, the relief is a cash subsidy that effectively reduces the cost basis of the investment.

The math is straightforward and creates a powerful, time-limited incentive. An investment of £50,000 made before the deadline yields a tax relief of £15,000. The same investment made after April 6 provides only £10,000 in relief. This £5,000 difference is a tangible, immediate return that is not available for the next tax year. The reduction is expected to have a significant impact on VCT fundraising, limiting the capital available to UK businesses seeking scale-up finance.

This policy change is the engine behind a classic sector rotation event. It concentrates institutional flow into VCTs for the 2025/26 tax year, as investors rush to deploy capital before the higher relief disappears. The evidence suggests this will cause popular VCTs to fill up even faster than usual. For a manager like Maven Capital Partners, this creates a favorable window to raise capital at a time of heightened demand, allowing them to deploy the full £12.5 million into their portfolio of regional unquoted businesses. The strategic rationale for the capital allocation remains, but the tax incentive provides the final, compelling push to execute.

Portfolio Impact and Risk-Adjusted Return

The new capital deployment is not a portfolio overhaul but a targeted expansion within a well-structured framework. The combined Maven VCTs operate a portfolio of over 100 private and AIM-quoted companies, a level of diversification that is critical for managing the inherent risks of early-stage investing. This breadth provides a structural tailwind, spreading exposure across sectors and company stages. The manager's own recent performance underscores this disciplined approach: in the year ended November 2025, the trust achieved a NAV total return of 152.82p per share, a 1.5% increase, while maintaining a 7% annual yield on NAV. This dual track record of capital growth and income generation is the hallmark of a quality factor strategy.

From a portfolio construction perspective, the fresh capital enhances the manager's ability to execute its regional focus. The trust completed two profitable private company exits last year and has a history of profitable realizations, generating £53.9 million in proceeds against a cost of £19.4 million over a recent 12-month period. The new funds allow for follow-on investments into existing portfolio companies and the addition of new regional ventures, reinforcing the strategy's momentum. The manager's autonomy and nationwide network, with 11 regional offices, are key enablers for sourcing these opportunities.

Yet the risk profile remains anchored in the nature of the underlying assets. The investments are in smaller, early stage companies that are inherently difficult to value and dispose of. This creates significant illiquidity and valuation risk-a core consideration for institutional investors assessing the quality factor. The high-yield, tax-advantaged structure of VCTs is designed to compensate for this, but the manager's success in delivering consistent returns hinges on its ability to navigate these frictions. The recent capital raise, therefore, represents a strategic bet on the manager's skill to deploy fresh capital into this high-risk, high-potential universe while maintaining the portfolio's essential diversification.

Catalysts, Scenarios, and What to Watch

The investment thesis now faces a clear sequence of forward-looking events. The primary catalyst is imminent. The tax relief cut to 20% from 6 April 2026 will fundamentally alter the risk-adjusted return equation for new VCT investments. This is not a minor policy tweak but a structural shift that will likely reduce the attractiveness of the asset class and constrain future fundraising. The market's reaction-investors rushing to deploy capital before the deadline-has already compressed the window for popular schemes. Post-April, the flow will reverse, testing the manager's ability to deploy the newly raised capital into a less liquid, higher-cost environment.

The efficacy of the capital deployment will be tested over the next 12 to 18 months. Institutional investors should monitor two key metrics. First, the manager's deployment pace and exit activity. The trust's recent history shows two profitable private company exits and a material partial realisation. The new capital must be put to work in a similar disciplined manner to generate the same path to returns. Second, watch for any regulatory changes to VCT gross asset limits. Evidence suggests these limits are being increased, allowing VCTs to invest in more mature businesses with gross assets up to £30 million instead of £15 million. This change, while partial mitigation, could improve the scheme's long-term appeal by slightly reducing the underlying risk profile. It is a potential tailwind that could help offset the negative impact of the tax relief cut.

The bottom line is a shift from a sector rotation event to a test of manager skill. The strategic rationale for deploying capital into a quality manager's portfolio remains, but the tax incentive that made it a compelling "buy now" proposition is disappearing. The coming months will reveal whether Maven Capital Partners can navigate this transition, deploying the full £12.5 million into its regional unquoted businesses and generating the profitable exits that have driven past returns. For institutional flows, the focus will be on execution, not just the initial capital raise.